APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medications for Treating Alcohol Dependence

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Medications for Treating Alcohol Dependence Market Analysis and Forecast 2026-2032

Report ID 174011380221 December 2025197 pages

Choose your research edition.

Industry ResearchMedications for Treating Alcohol Dependence Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Medications for Treating Alcohol Dependence Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Medications for Treating Alcohol Dependence Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medications for Treating Alcohol Dependence Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Medications for Treating Alcohol Dependence Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Medications for Treating Alcohol Dependence market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medications for Treating Alcohol Dependence is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medications for Treating Alcohol Dependence is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medications for Treating Alcohol Dependence is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medications for Treating Alcohol Dependence is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medications for Treating Alcohol Dependence include Teva, Sun Pharmaceutical Industries, Merck Group, Mylan, Zydus Pharmaceuticals, Glenmark Pharmaceuticals, Beijing Wellso Pharmaceutical Co, Taj Pharmaceuticals and TAGI Pharma Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medications for Treating Alcohol Dependence, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medications for Treating Alcohol Dependence, also provides the revenue of main regions and countries. Of the upcoming market potential for Medications for Treating Alcohol Dependence, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medications for Treating Alcohol Dependence revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medications for Treating Alcohol Dependence market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medications for Treating Alcohol Dependence revenue, projected growth trends, production technology, application and end-user industry.

Medications for Treating Alcohol Dependence Segment by Company

Teva

Sun Pharmaceutical Industries

Merck Group

Mylan

Zydus Pharmaceuticals

Glenmark Pharmaceuticals

Beijing Wellso Pharmaceutical Co

Taj Pharmaceuticals

TAGI Pharma Inc.

Rusan Pharma Ltd

Lundbeck

Alvogen

Alkermes Inc

Medications for Treating Alcohol Dependence Segment by Type

Disulfiram

Naltrexone

Acamprosate

Other

Medications for Treating Alcohol Dependence Segment by Application

Clinic

Hospital

Retail Pharmacies

Rehabilitation Institutions

Medications for Treating Alcohol Dependence Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medications for Treating Alcohol Dependence market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medications for Treating Alcohol Dependence and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medications for Treating Alcohol Dependence.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medications for Treating Alcohol Dependence in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medications for Treating Alcohol Dependence company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medications for Treating Alcohol Dependence revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medications for Treating Alcohol Dependence Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Disulfiram Major Player Table 3. Naltrexone Major Player Table 4. Acamprosate Major Player Table 5. Other Major Player Table 6. Global Medications for Treating Alcohol Dependence Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinic Major Player Table 8. Hospital Major Player Table 9. Retail Pharmacies Major Player Table 10. Rehabilitation Institutions Major Player Table 11. Medications for Treating Alcohol Dependence Industry Trends Table 12. Medications for Treating Alcohol Dependence Industry Drivers Table 13. Medications for Treating Alcohol Dependence Industry Opportunities and Challenges Table 14. Medications for Treating Alcohol Dependence Industry Restraints Table 15. Global Medications for Treating Alcohol Dependence Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Medications for Treating Alcohol Dependence Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Medications for Treating Alcohol Dependence Market Share by Region (2021-2026) Table 18. Global Medications for Treating Alcohol Dependence Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Medications for Treating Alcohol Dependence Market Share by Region (2027-2032) Table 20. Global Medications for Treating Alcohol Dependence Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Medications for Treating Alcohol Dependence Revenue Market Share by Players (2021-2026) Table 22. Global Medications for Treating Alcohol Dependence Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Medications for Treating Alcohol Dependence Key Players Headquarters & Area Served Table 24. Global Medications for Treating Alcohol Dependence Players, Product Type & Application Table 25. Global Medications for Treating Alcohol Dependence Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Medications for Treating Alcohol Dependence by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Medications for Treating Alcohol Dependence Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Medications for Treating Alcohol Dependence Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Medications for Treating Alcohol Dependence Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Medications for Treating Alcohol Dependence Revenue Market Share by Type (2021-2026) Table 32. Global Medications for Treating Alcohol Dependence Revenue Market Share by Type (2027-2032) Table 33. Global Medications for Treating Alcohol Dependence Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Medications for Treating Alcohol Dependence Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Medications for Treating Alcohol Dependence Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Medications for Treating Alcohol Dependence Revenue Market Share by Application (2021-2026) Table 37. Global Medications for Treating Alcohol Dependence Revenue Market Share by Application (2027-2032) Table 38. Teva Company Information Table 39. Teva Business Overview Table 40. Teva Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Teva Medications for Treating Alcohol Dependence Product Portfolio Table 42. Teva Recent Development Table 43. Sun Pharmaceutical Industries Company Information Table 44. Sun Pharmaceutical Industries Business Overview Table 45. Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Product Portfolio Table 47. Sun Pharmaceutical Industries Recent Development Table 48. Merck Group Company Information Table 49. Merck Group Business Overview Table 50. Merck Group Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Merck Group Medications for Treating Alcohol Dependence Product Portfolio Table 52. Merck Group Recent Development Table 53. Mylan Company Information Table 54. Mylan Business Overview Table 55. Mylan Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Mylan Medications for Treating Alcohol Dependence Product Portfolio Table 57. Mylan Recent Development Table 58. Zydus Pharmaceuticals Company Information Table 59. Zydus Pharmaceuticals Business Overview Table 60. Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio Table 62. Zydus Pharmaceuticals Recent Development Table 63. Glenmark Pharmaceuticals Company Information Table 64. Glenmark Pharmaceuticals Business Overview Table 65. Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio Table 67. Glenmark Pharmaceuticals Recent Development Table 68. Beijing Wellso Pharmaceutical Co Company Information Table 69. Beijing Wellso Pharmaceutical Co Business Overview Table 70. Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Product Portfolio Table 72. Beijing Wellso Pharmaceutical Co Recent Development Table 73. Taj Pharmaceuticals Company Information Table 74. Taj Pharmaceuticals Business Overview Table 75. Taj Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Taj Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio Table 77. Taj Pharmaceuticals Recent Development Table 78. TAGI Pharma Inc. Company Information Table 79. TAGI Pharma Inc. Business Overview Table 80. TAGI Pharma Inc. Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. TAGI Pharma Inc. Medications for Treating Alcohol Dependence Product Portfolio Table 82. TAGI Pharma Inc. Recent Development Table 83. Rusan Pharma Ltd Company Information Table 84. Rusan Pharma Ltd Business Overview Table 85. Rusan Pharma Ltd Medications for Treating Alcohol Dependence Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Rusan Pharma Ltd Medications for Treating Alcohol Dependence Product Portfolio Table 87. Rusan Pharma Ltd Recent Development Table 88. Lundbeck Company Information Table 89. Lundbeck Business Overview Table 90. Lundbeck Medications for Treating Alcohol Dependence Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Lundbeck Medications for Treating Alcohol Dependence Product Portfolio Table 92. Lundbeck Recent Development Table 93. Alvogen Company Information Table 94. Alvogen Business Overview Table 95. Alvogen Medications for Treating Alcohol Dependence Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Alvogen Medications for Treating Alcohol Dependence Product Portfolio Table 97. Alvogen Recent Development Table 98. Alkermes Inc Company Information Table 99. Alkermes Inc Business Overview Table 100. Alkermes Inc Medications for Treating Alcohol Dependence Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Alkermes Inc Medications for Treating Alcohol Dependence Product Portfolio Table 102. Alkermes Inc Recent Development Table 103. North America Medications for Treating Alcohol Dependence Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Medications for Treating Alcohol Dependence Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Medications for Treating Alcohol Dependence Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Medications for Treating Alcohol Dependence Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Medications for Treating Alcohol Dependence Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Medications for Treating Alcohol Dependence Revenue by Country (2021-2026) & (US$ Million) Table 109. North America Medications for Treating Alcohol Dependence Revenue by Country (US$ Million) & (2027-2032) Table 110. Europe Medications for Treating Alcohol Dependence Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Medications for Treating Alcohol Dependence Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Medications for Treating Alcohol Dependence Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Medications for Treating Alcohol Dependence Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Medications for Treating Alcohol Dependence Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Medications for Treating Alcohol Dependence Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Medications for Treating Alcohol Dependence Revenue by Country (US$ Million) & (2027-2032) Table 117. China Medications for Treating Alcohol Dependence Revenue by Type (2021-2026) & (US$ Million) Table 118. China Medications for Treating Alcohol Dependence Revenue by Type (2027-2032) & (US$ Million) Table 119. China Medications for Treating Alcohol Dependence Revenue by Application (2021-2026) & (US$ Million) Table 120. China Medications for Treating Alcohol Dependence Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Medications for Treating Alcohol Dependence Revenue by Type (2021-2026) & (US$ Million) Table 122. Asia Medications for Treating Alcohol Dependence Revenue by Type (2027-2032) & (US$ Million) Table 123. Asia Medications for Treating Alcohol Dependence Revenue by Application (2021-2026) & (US$ Million) Table 124. Asia Medications for Treating Alcohol Dependence Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Medications for Treating Alcohol Dependence Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Asia Medications for Treating Alcohol Dependence Revenue by Region (US$ Million) & (2021-2026) Table 127. Asia Medications for Treating Alcohol Dependence Revenue by Region (US$ Million) & (2027-2032) Table 128. SAMEA Medications for Treating Alcohol Dependence Revenue by Type (2021-2026) & (US$ Million) Table 129. SAMEA Medications for Treating Alcohol Dependence Revenue by Type (2027-2032) & (US$ Million) Table 130. SAMEA Medications for Treating Alcohol Dependence Revenue by Application (2021-2026) & (US$ Million) Table 131. SAMEA Medications for Treating Alcohol Dependence Revenue by Application (2027-2032) & (US$ Million) Table 132. SAMEA Medications for Treating Alcohol Dependence Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. SAMEA Medications for Treating Alcohol Dependence Revenue by Country (2021-2026) & (US$ Million) Table 134. SAMEA Medications for Treating Alcohol Dependence Revenue by Country (US$ Million) & (2027-2032) Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Medications for Treating Alcohol Dependence Image Figure 2. Global Medications for Treating Alcohol Dependence Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medications for Treating Alcohol Dependence Market Size Share 2021 VS 2025 VS 2032 Figure 4. Disulfiram Image Figure 5. Naltrexone Image Figure 6. Acamprosate Image Figure 7. Other Image Figure 8. Global Medications for Treating Alcohol Dependence Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Medications for Treating Alcohol Dependence Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinic Image Figure 11. Hospital Image Figure 12. Retail Pharmacies Image Figure 13. Rehabilitation Institutions Image Figure 14. Global Medications for Treating Alcohol Dependence Market Size (US$ Million) & (2021-2032) Figure 15. Global Medications for Treating Alcohol Dependence Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Medications for Treating Alcohol Dependence Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Medications for Treating Alcohol Dependence Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Medications for Treating Alcohol Dependence Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Medications for Treating Alcohol Dependence Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Medications for Treating Alcohol Dependence Revenue Market Share by Type (2021-2032) Figure 22. Global Medications for Treating Alcohol Dependence Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Medications for Treating Alcohol Dependence Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Medications for Treating Alcohol Dependence Revenue Market Share by Application (2021-2032) Figure 25. North America Medications for Treating Alcohol Dependence Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032) Figure 27. North America Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032) Figure 28. North America Medications for Treating Alcohol Dependence Revenue Share by Country (2021-2032) Figure 29. United States Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Medications for Treating Alcohol Dependence Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032) Figure 34. Europe Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032) Figure 35. Europe Medications for Treating Alcohol Dependence Revenue Share by Country (2021-2032) Figure 36. Germany Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Medications for Treating Alcohol Dependence Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032) Figure 46. China Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032) Figure 47. Asia Medications for Treating Alcohol Dependence Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032) Figure 49. Asia Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032) Figure 50. Asia Medications for Treating Alcohol Dependence Revenue Share by Region (2021-2032) Figure 51. Japan Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Medications for Treating Alcohol Dependence Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032) Figure 59. SAMEA Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032) Figure 60. SAMEA Medications for Treating Alcohol Dependence Revenue Share by Country (2021-2032) Figure 61. Brazil Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Medications for Treating Alcohol Dependence Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Disulfiram
  • Naltrexone
  • Acamprosate
  • Other
Applications
  • Clinic
  • Hospital
  • Retail Pharmacies
  • Rehabilitation Institutions
Companies covered
  • Teva
  • Sun Pharmaceutical Industries
  • Merck Group
  • Mylan
  • Zydus Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Beijing Wellso Pharmaceutical Co
  • Taj Pharmaceuticals
  • TAGI Pharma Inc.
  • Rusan Pharma Ltd
  • Lundbeck
  • Alvogen
  • Alkermes Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medications for Treating Alcohol Dependence Market by Type
  3. 1.2.1 Global Medications for Treating Alcohol Dependence Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Disulfiram
  5. 1.2.3 Naltrexone
  6. 1.2.4 Acamprosate
  7. 1.2.5 Other
  8. 1.3 Medications for Treating Alcohol Dependence Market by Application
  9. 1.3.1 Global Medications for Treating Alcohol Dependence Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinic
  11. 1.3.3 Hospital
  12. 1.3.4 Retail Pharmacies
  13. 1.3.5 Rehabilitation Institutions
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Medications for Treating Alcohol Dependence Market Dynamics
  1. 2.1 Medications for Treating Alcohol Dependence Industry Trends
  2. 2.2 Medications for Treating Alcohol Dependence Industry Drivers
  3. 2.3 Medications for Treating Alcohol Dependence Industry Opportunities and Challenges
  4. 2.4 Medications for Treating Alcohol Dependence Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medications for Treating Alcohol Dependence Market Perspective (2021-2032)
  2. 3.2 Global Medications for Treating Alcohol Dependence Growth Trends by Region
  3. 3.2.1 Global Medications for Treating Alcohol Dependence Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medications for Treating Alcohol Dependence Market Size by Region (2021-2026)
  5. 3.2.3 Global Medications for Treating Alcohol Dependence Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medications for Treating Alcohol Dependence Revenue by Players
  2. 4.1.1 Global Medications for Treating Alcohol Dependence Revenue by Players (2021-2026)
  3. 4.1.2 Global Medications for Treating Alcohol Dependence Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medications for Treating Alcohol Dependence Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medications for Treating Alcohol Dependence Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medications for Treating Alcohol Dependence Key Players Headquarters & Area Served
  7. 4.4 Global Medications for Treating Alcohol Dependence Players, Product Type & Application
  8. 4.5 Global Medications for Treating Alcohol Dependence Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medications for Treating Alcohol Dependence Market CR5 and HHI
  11. 4.6.3 2025 Medications for Treating Alcohol Dependence Tier 1, Tier 2, and Tier 3
5 Medications for Treating Alcohol Dependence Market Size by Type
  1. 5.1 Global Medications for Treating Alcohol Dependence Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medications for Treating Alcohol Dependence Revenue by Type (2021-2032)
  3. 5.3 Global Medications for Treating Alcohol Dependence Revenue Market Share by Type (2021-2032)
6 Medications for Treating Alcohol Dependence Market Size by Application
  1. 6.1 Global Medications for Treating Alcohol Dependence Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medications for Treating Alcohol Dependence Revenue by Application (2021-2032)
  3. 6.3 Global Medications for Treating Alcohol Dependence Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Medications for Treating Alcohol Dependence Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sun Pharmaceutical Industries
  8. 7.2.1 Sun Pharmaceutical Industries Company Information
  9. 7.2.2 Sun Pharmaceutical Industries Business Overview
  10. 7.2.3 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Industries Recent Developments
  13. 7.3 Merck Group
  14. 7.3.1 Merck Group Company Information
  15. 7.3.2 Merck Group Business Overview
  16. 7.3.3 Merck Group Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Merck Group Medications for Treating Alcohol Dependence Product Portfolio
  18. 7.3.5 Merck Group Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Medications for Treating Alcohol Dependence Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Zydus Pharmaceuticals
  26. 7.5.1 Zydus Pharmaceuticals Company Information
  27. 7.5.2 Zydus Pharmaceuticals Business Overview
  28. 7.5.3 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
  30. 7.5.5 Zydus Pharmaceuticals Recent Developments
  31. 7.6 Glenmark Pharmaceuticals
  32. 7.6.1 Glenmark Pharmaceuticals Company Information
  33. 7.6.2 Glenmark Pharmaceuticals Business Overview
  34. 7.6.3 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
  36. 7.6.5 Glenmark Pharmaceuticals Recent Developments
  37. 7.7 Beijing Wellso Pharmaceutical Co
  38. 7.7.1 Beijing Wellso Pharmaceutical Co Company Information
  39. 7.7.2 Beijing Wellso Pharmaceutical Co Business Overview
  40. 7.7.3 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Product Portfolio
  42. 7.7.5 Beijing Wellso Pharmaceutical Co Recent Developments
  43. 7.8 Taj Pharmaceuticals
  44. 7.8.1 Taj Pharmaceuticals Company Information
  45. 7.8.2 Taj Pharmaceuticals Business Overview
  46. 7.8.3 Taj Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Taj Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
  48. 7.8.5 Taj Pharmaceuticals Recent Developments
  49. 7.9 TAGI Pharma Inc.
  50. 7.9.1 TAGI Pharma Inc. Company Information
  51. 7.9.2 TAGI Pharma Inc. Business Overview
  52. 7.9.3 TAGI Pharma Inc. Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  53. 7.9.4 TAGI Pharma Inc. Medications for Treating Alcohol Dependence Product Portfolio
  54. 7.9.5 TAGI Pharma Inc. Recent Developments
  55. 7.10 Rusan Pharma Ltd
  56. 7.10.1 Rusan Pharma Ltd Company Information
  57. 7.10.2 Rusan Pharma Ltd Business Overview
  58. 7.10.3 Rusan Pharma Ltd Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Rusan Pharma Ltd Medications for Treating Alcohol Dependence Product Portfolio
  60. 7.10.5 Rusan Pharma Ltd Recent Developments
  61. 7.11 Lundbeck
  62. 7.11.1 Lundbeck Company Information
  63. 7.11.2 Lundbeck Business Overview
  64. 7.11.3 Lundbeck Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Lundbeck Medications for Treating Alcohol Dependence Product Portfolio
  66. 7.11.5 Lundbeck Recent Developments
  67. 7.12 Alvogen
  68. 7.12.1 Alvogen Company Information
  69. 7.12.2 Alvogen Business Overview
  70. 7.12.3 Alvogen Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Alvogen Medications for Treating Alcohol Dependence Product Portfolio
  72. 7.12.5 Alvogen Recent Developments
  73. 7.13 Alkermes Inc
  74. 7.13.1 Alkermes Inc Company Information
  75. 7.13.2 Alkermes Inc Business Overview
  76. 7.13.3 Alkermes Inc Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Alkermes Inc Medications for Treating Alcohol Dependence Product Portfolio
  78. 7.13.5 Alkermes Inc Recent Developments
8 North America
  1. 8.1 North America Medications for Treating Alcohol Dependence Revenue (2021-2032)
  2. 8.2 North America Medications for Treating Alcohol Dependence Revenue by Type (2021-2032)
  3. 8.2.1 North America Medications for Treating Alcohol Dependence Revenue by Type (2021-2026)
  4. 8.2.2 North America Medications for Treating Alcohol Dependence Revenue by Type (2027-2032)
  5. 8.3 North America Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032)
  6. 8.4 North America Medications for Treating Alcohol Dependence Revenue by Application (2021-2032)
  7. 8.4.1 North America Medications for Treating Alcohol Dependence Revenue by Application (2021-2026)
  8. 8.4.2 North America Medications for Treating Alcohol Dependence Revenue by Application (2027-2032)
  9. 8.5 North America Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032)
  10. 8.6 North America Medications for Treating Alcohol Dependence Revenue by Country
  11. 8.6.1 North America Medications for Treating Alcohol Dependence Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medications for Treating Alcohol Dependence Revenue by Country (2021-2026)
  13. 8.6.3 North America Medications for Treating Alcohol Dependence Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medications for Treating Alcohol Dependence Revenue (2021-2032)
  2. 9.2 Europe Medications for Treating Alcohol Dependence Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medications for Treating Alcohol Dependence Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medications for Treating Alcohol Dependence Revenue by Type (2027-2032)
  5. 9.3 Europe Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medications for Treating Alcohol Dependence Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medications for Treating Alcohol Dependence Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medications for Treating Alcohol Dependence Revenue by Application (2027-2032)
  9. 9.5 Europe Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medications for Treating Alcohol Dependence Revenue by Country
  11. 9.6.1 Europe Medications for Treating Alcohol Dependence Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medications for Treating Alcohol Dependence Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medications for Treating Alcohol Dependence Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medications for Treating Alcohol Dependence Revenue (2021-2032)
  2. 10.2 China Medications for Treating Alcohol Dependence Revenue by Type (2021-2032)
  3. 10.2.1 China Medications for Treating Alcohol Dependence Revenue by Type (2021-2026)
  4. 10.2.2 China Medications for Treating Alcohol Dependence Revenue by Type (2027-2032)
  5. 10.3 China Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032)
  6. 10.4 China Medications for Treating Alcohol Dependence Revenue by Application (2021-2032)
  7. 10.4.1 China Medications for Treating Alcohol Dependence Revenue by Application (2021-2026)
  8. 10.4.2 China Medications for Treating Alcohol Dependence Revenue by Application (2027-2032)
  9. 10.5 China Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medications for Treating Alcohol Dependence Revenue (2021-2032)
  2. 11.2 Asia Medications for Treating Alcohol Dependence Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medications for Treating Alcohol Dependence Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medications for Treating Alcohol Dependence Revenue by Type (2027-2032)
  5. 11.3 Asia Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medications for Treating Alcohol Dependence Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medications for Treating Alcohol Dependence Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medications for Treating Alcohol Dependence Revenue by Application (2027-2032)
  9. 11.5 Asia Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medications for Treating Alcohol Dependence Revenue by Country
  11. 11.6.1 Asia Medications for Treating Alcohol Dependence Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medications for Treating Alcohol Dependence Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medications for Treating Alcohol Dependence Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medications for Treating Alcohol Dependence Revenue (2021-2032)
  2. 12.2 SAMEA Medications for Treating Alcohol Dependence Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medications for Treating Alcohol Dependence Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medications for Treating Alcohol Dependence Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medications for Treating Alcohol Dependence Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medications for Treating Alcohol Dependence Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medications for Treating Alcohol Dependence Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medications for Treating Alcohol Dependence Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medications for Treating Alcohol Dependence Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medications for Treating Alcohol Dependence Revenue by Country
  11. 12.6.1 SAMEA Medications for Treating Alcohol Dependence Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medications for Treating Alcohol Dependence Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medications for Treating Alcohol Dependence Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst